About SinoVeda Canada Inc.

SinoVeda Canada Inc. [ˈsaɪ-nəʊ ˈveɪ-də] was co-founded by Dr. Yun Tam and Dr. Nuzhat Tam-Zaman in 2006. Their aim was to bridge the wisdom of natural medicine from around the world with their extensive education in Pharmacokinetics and clinical evaluation. The foundation of SinoVeda Canada Inc. is the patented Pharmaceutical Platform Technology® (PPT®) developed by Dr. Tam that enables the development of multi-active, multi-target pharmaceutical products.

SinoVeda Canada Inc. has two divisions: Research and Development (R&D) and Consumer Health. The R&D team focuses on advancing PPT® in four scientific departments: molecular pharmacology, analytical chemistry, computational engineering and physics, and quality control and quality assurance. The Consumer Health team manages regulatory affairs, the supply chain, product manufacturing, marketing, sales, distribution, exporting, and customer service for SinoVeda’s products.

 

Our Management Team

Dr. Yun Tam

DR. YUN TAM, BS., MSc., Ph.D.

CO-FOUNDER, PRESIDENT, and CSO

Dr. Tam is the lead inventor of the Pharmaceutical Platform Technology® (PPT®) that enables the development of multi-active, multi-target pharmaceutical products. Born and raised in Hong Kong, he was brought up using Traditional Chinese Medicine for health and wellness to prevent and fight disease. Dr. Tam’s passion is pharmaceutical innovation with a personal vision to cure drug-resistant malaria and neurodegenerative diseases.

After earning his bachelor’s degree in biology at the University of Minnesota, MSc. and Ph.D. in Pharmaceutical Sciences at the University of British Columbia, Dr. Tam moved to Edmonton to be a Professor at the University of Alberta in the Faculty of Pharmacy & Pharmaceutical Sciences. During his tenure as a professor, his research focused on applied theoretical and predictive pharmacokinetics for 20 years. He also taught classes and supervised 15 Ph.D. students - one who became his life partner and business partner, Dr. Nuzhat Tam-Zaman.

Dr. Tam also has extensive experience as a consultant to multinational, national and local pharmaceutical companies. In 2002, he had the experience of taking his previous pharmaceutical company public in the Hong Kong stock exchange.

He holds five US patents, two international patents, has published 100+ refereed articles and book chapters, and speaks nationally and internationally. Dr. Tam sits on the Editorial Advisory Board of Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition and serves as review editor for Frontiers in Pharmacology, Ethnopharmacology Section and is also a member of College of Reviewers, the Canadian Institute of Health Research.


Dr. Nuzhat Tam-Zaman

DR. NUZHAT TAM-ZAMAN, B.Pharm., M.Pharm., Ph.D.

CO-FOUNDER and VICE PRESIDENT OF CONSUMER HEALTH

Born and raised in Bangladesh, Dr. Tam-Zaman grew up with Ayurvedic medicine practices and values holistic health. She earned her bachelor’s degree and master’s degree in pharmacy focusing on phytochemistry (plant medicine). Dr. Tam-Zaman came to Edmonton on a Commonwealth scholarship to do her Ph.D. in Pharmacokinetics at the University of Alberta.

Dr. Tam-Zaman leads the Consumer Health division and has managed to get approvals for 14 natural health products with Natural and Non-prescription Health Products (NNHPD) in Canada and one product with Generally Recognized as Safe (GRAS) status from the United States. She is well versed with regulatory affairs, pre-clinical and clinical testing, setting up the supply chain, production of each product, registrations with the Compendium of Pharmaceuticals and Specialties (CPS), OTC monographs in USFDA, and arranging global distribution channels - registering SinoVeda’s products in local and foreign jurisdictions including: Canada, Bangladesh, Hong Kong, United States, Kuwait, Qatar, Korea, Japan, and India. Her personal vision is to have SinoVeda’s premium products in every medicine cabinet and handbag in North America and to have distribution partners globally.

As a Bangladeshi-Canadian woman entrepreneur in Alberta, Dr. Nuzhat Tam-Zaman believes in and fights for diversity and inclusion in the workplace. In 2011, both Dr. Tam Zaman and Dr. Tam were recipients of a Scientific Achievement and Innovation Award from BioAlberta. Dr. Tam-Zaman is now a board member of BioAlberta and a scientific advisory board member of Hyasynth Biologicals Inc.

The Sinoveda Team

DR. TRENT C. BJORNDAHL, BSc. (Pharm), R.Ph., Ph.D.

DR. TRENT C. BJORNDAHL, BSc. (Pharm), R.Ph., Ph.D.

HEAD, MOLECULAR PHARMACOLOGY DIVISION

Using state of the art organoid-based disease models, Dr. Bjorndahl’s team utilizes the plant extracts prepared by SinoVeda’s analytical chemistry division to screen for disease modifying effects with polymerase chain reaction (PCR) and immunofluorescent techniques. The team also performs cell based in-vitro pharmacokinetic analysis of lead compounds and extracts to better predict the drug like properties of potential candidates.

,

HEAD, ANALYTICAL CHEMISTRY DIVISION

Coming soon.

DR. CHIH-YUAN (RICHARD) TSENG, Ph.D.

DR. CHIH-YUAN (RICHARD) TSENG, Ph.D.

HEAD, COMPUTATIONAL DIVISION

The goal of Dr. Tseng’s team is to utilize interdisciplinary computational approaches to pursue SinoVeda’s vision to develop effective and affordable medicines. Dr. Tseng manages the team to apply physics, mathematics and computational biology to conduct research to advance SinoVeda’s Pharmaceutical Platform Technology® (PPT). The team also performs in-silico analysis on data from molecular pharmacology division and provides pharmacokinetic and pharmacodynamic assessment for product development.

EVAN HOLE, BSc.

EVAN HOLE, BSc.

QUALITY ASSURANCE AND QUALITY CONTROL OFFICER

Evan oversees the quality management systems at SinoVeda, including a centralized quality management system, system validations, and electronic laboratory notebooks. Evan manages both manufacturing and laboratory quality measures to ensure that quality is maintained from the earliest research to the finished product.

OUR EXTERNAL BOARD OF DIRECTORS

MR. GRANT FERRIER, B.S.

FOUNDER OF NUTRITIONAL BUSINESS JOURNAL

DR. KEITH CHAN, Ph.D.

FORMER DIRECTOR OF GENERIC DRUGS, U.S. FDA, FOUNDER OF GLOBOMAX